Spotlight On: Nephrology

Secondary hyperparathyroidism, also known as sHPT, is one of the particularly challenging aspects of treating patients with chronic kidney disease who are on hemodialysis. And while nephrology patients seem to be an underserved patient population when it comes to treatment options, there are still some important advances to be aware of, like an IV-administered treatment option for sHPT.

So tune in to this three-part series to learn more about this treatment option, recent dosing practices with oral cinacalcet, and how the changing dynamics of nephrology care are affecting some patients with sHPT.